US Bancorp’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX.PRA
US Bancorp's BSX.PRA Position: Q2 2023 in Review
US Bancorp sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 300 shares — an estimated $36.3K sold.
US Bancorp first reported a position in BSX.PRA in Q4 2022 and held it in 2 quarters. The position peaked at $36.3K in Q1 2023. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.
- US Bancorp reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
- US Bancorp sold 300 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $36.3K.
- US Bancorp first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q4 2022 and held it in 2 quarters.
- US Bancorp's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $36.3K in Q1 2023.
- 1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.
Based on US Bancorp's 13F filing for Q2 2023, filed 10 Aug 2023.